Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.

ABSTRACT:

SUBMITTER: Grogan PT 

PROVIDER: S-EPMC9167633 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature